866-997-4948 (US-Canada Toll Free)

Browse All Genomics Market Research Reports

  • Global Genomics Industry 2015 Market Research Report

    Aug 2015

    By QYResearch

    Biotechnology

    173 Pages

    The Global Genomics Industry Report 2015 is a professional and in-depth study on the current state of the Genomics industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Genomics market analysis is provided for the international markets including development trends, competitive landscape analysis,...

    USD 2800View Report
  • Genomics Deals and Alliances of 2014

    Mar 2015

    By Current Partnering

    Biotechnology

    200 Pages

    The Genomics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view...

    USD 1495View Report
  • Quantum Genomics SA - Product Pipeline Review - 2015

    Feb 2015

    By Global Markets Direct

    Pharmaceutical

    23 Pages

    Global Markets Directs, Quantum Genomics SA Product Pipeline Review 2015, provides an overview of the Quantum Genomics SAs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Quantum Genomics SAs, complete with comparative analysis at various stages, therapeutics assessment by drug...

    USD 1500View Report
  • QUANTUM GENOMICS Corp. - Product Pipeline Review - 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    23 Pages

    QUANTUM GENOMICS Corp. - Product Pipeline Review - 2014 Summary Global Markets Directs, QUANTUM GENOMICS Corp. - Product Pipeline Review - 2014, provides an overview of the QUANTUM GENOMICS Corp.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of QUANTUM GENOMICS Corp.s, complete with comparative...

    USD 1500View Report
  • Virogenomics, Inc. - Product Pipeline Review - 2014

    Dec 2014

    By Global Markets Direct

    Pharmaceutical

    18 Pages

    Virogenomics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Directs, Virogenomics, Inc. - Product Pipeline Review - 2014, provides an overview of the Virogenomics, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Virogenomics, Inc.s, complete with comparative analysis at...

    USD 1500View Report
  • Orion Genomics LLC - Product Pipeline Analysis, 2014 Update

    Dec 2014

    By GlobalData

    Medical Equipments

    31 Pages

    Orion Genomics LLC (Orion Genomics) is a provider of epigenetic research tools and molecular diagnostic products. Its products include colon cancer risk test, bladder cancer screening and lung cancer screening system, and biomarker. Orion Genomics offers diagnostic test products for breast, lung, ovarian, colorectal and other diseases. The company also provides genomics research and...

  • Oryzon Genomics S.A. - Product Pipeline Review - 2014

    Nov 2014

    By Global Markets Direct

    Pharmaceutical

    31 Pages

    Oryzon Genomics S.A. - Product Pipeline Review - 2014 Summary Global Markets Directs, Oryzon Genomics S.A. - Product Pipeline Review - 2014, provides an overview of the Oryzon Genomics S.A.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Oryzon Genomics S.A.s, complete with comparative...

    USD 1500View Report
  • Pharmacogenomics Partnering Terms and Agreements

    Nov 2014

    By Current Partnering

    Biotechnology

    455 Pages

    The Pharmacogenomics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter pharmacogenomics partnering deals. The majority of deals...

    USD 1995View Report
  • Oryzon Genomics S.A. - Product Pipeline Analysis, 2014 Update

    Sep 2014

    By GlobalData

    Medical Equipments

    20 Pages

    Oryzon Genomics S.A. (Oryzon) is a biopharmaceutical company. The company develops therapies and biological solutions for cancer and neurodegenerative diseases. It concentrates on the exploitation of biomarkers identified through genomics and proteomics in diagnostics, personalized medicine and therapy fields. Oryzons diagnostic products include GynEC-DX for endometrial cancer; Cxbladder...

  • Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis, 2014 Update

    Sep 2014

    By GlobalData

    Medical Equipments

    37 Pages

    Rosetta Genomics, Ltd. (RGL) is a biotechnology company. The company discovers, develops and commercializes next generation diagnostic tests for personalized medicine. It provides testing services such as rosetta cancer origin test, resetta lung cancer test, rosetta kidney cancer test and rosetta mesothelioma test. RGL product pipeline includes tests such as thyroid neoplasia, oncology...

  • Genomics Deals and Alliances of 2013

    Aug 2014

    By Current Partnering

    Biotechnology

    200 Pages

    The Genomics Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view...

    USD 1495View Report
  • CrystalGenomics, Inc. - Product Pipeline Review - 2014

    Jun 2014

    By Global Markets Direct

    Pharmaceutical

    44 Pages

    CrystalGenomics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Directs, CrystalGenomics, Inc. - Product Pipeline Review - 2014, provides an overview of the CrystalGenomics, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of CrystalGenomics, Inc.s, complete with comparative...

    USD 1500View Report
  • Accugenomics, Inc. - Product Pipeline Analysis, 2013 Update

    Dec 2013

    By GlobalData

    Medical Equipments

    19 Pages

    AccuGenomics, Inc. (AccuGenomics) is a diagnostic company. The company provides gene expression tests which diagnose, monitor and inform cancer treatment. It concentrates on developing standardized molecular diagnostic tests utilizing its patented technology in the field of oncology. AccuGenomics diagnostic tests include standardized BCR-ABL molecular diagnostics test, lung cancer risk...

  • Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis, 2013 Update

    Oct 2013

    By GlobalData

    Medical Equipments

    108 Pages

    Rosetta Genomics, Ltd. (RGL) is a biotechnology company. The company discovers, develops and commercializes next generation diagnostic tests for personalized medicine. Its products under clinical development include miRview, Rosetta Mesothelioma Test, Rosetta Cancer Origin Test, Rosetta Lung Cancer Test and Rosetta Kidney Cancer Test. RGL offers services such as testing services, gene...

  • Genomics And Proteomics Reagents, Research Kits and Analytical Instruments Market (Sample Preparation, Electrophoresis, BioChips and Microarrays, Chromatography, Mass Spectrometry, Thermal Cyclers, Next-Gen Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

    Aug 2013

    By Transparency

    Biotechnology

    115 Pages

    Genomics and proteomics have greatly increased the volume and quality of information with regards to several lesser known genetic diseases and as such have expedited the cure for many illnesses. The market report encompasses the various technologies that account for genomics and proteomics research by various end users such as drug discovery and development, life-science research such...

    USD 4595View Report
  • Oryzon Genomics S.A. - Product Pipeline Review - 2013

    Jun 2013

    By Global Markets Direct

    Pharmaceutical

    38 Pages

    Global Market Directs pharmaceuticals report, Oryzon Genomics S.A. Product Pipeline Review 2013 provides data on the Oryzon Genomics S.A.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced...

    USD 1500View Report
  • Oryzon Genomics S.A. - Product Pipeline Analysis, 2013 Update

    Jun 2013

    By GlobalData

    Medical Equipments

    25 Pages

    Oryzon Genomics (Oryzon) is a biopharmaceutical company. It develops therapies and biological solutions for cancer and neurodegenerative diseases. The company specializes in the field of preventative medicine. It carries out its operations under three business units, namely, Diagnostics, Personalized Medicine and Therapy. The companys diagnostic products in pipeline include GynEC-DX for...

  • AbGenomics International, Inc. - Product Pipeline Review - 2013

    May 2013

    By Global Markets Direct

    Pharmaceutical

    28 Pages

    Global Market Directs pharmaceuticals report, AbGenomics International, Inc. Product Pipeline Review 2013 provides data on the AbGenomics International, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and...

    USD 1500View Report
  • Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokinetics, Human Simulation Software, Drug Discovery & Development) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

    May 2013

    By Transparency

    Surgical Equipment

    112 Pages

    The computational biology market is predicted to have a notable growth owing to its wide use by biotechnology and pharmaceutical companies to reduce the incidences of late stage failures of their drugs and to thereby curb R&D expenditure. Computational biology is also assisting in reducing the extensive use of humans in trials and is therefore useful for pediatric trials, trials on...

    USD 4595View Report
  • CrystalGenomics, Inc. Product Pipeline Review 2012

    Dec 2012

    By Global Markets Direct

    Pharmaceutical

    47 Pages

    Global Market Directs pharmaceuticals report, CrystalGenomics, Inc. Product Pipeline Review 2012 provides data on the CrystalGenomics, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced...

    USD 1500View Report
  • Inform Genomics, Inc. - Product Pipeline Analysis

    Dec 2012

    By GlobalData

    Surgical Equipment

    18 Pages

    Inform Genomics, Inc. (Inform Genomics) is a development stage pharmaceutical company. The develops medicine products for cancer supportive care and inflammatory diseases. Its development stage products include OnPART, transplant test and InPART. The OnPART, Oncology Preferences And Risk of Toxicity, is used for treatment decisions in patients who receive chemotherapy for colorectal,...

  • Accugenomics, Inc. - Product Pipeline Analysis

    Dec 2012

    By GlobalData

    Surgical Equipment

    19 Pages

    AccuGenomics, Inc. (AccuGenomics) is a US-based diagnostic company that concentrates on developing standardized molecular diagnostic tests utilizing its patented technology in the field of oncology. The company develops gene expression tests that provide genomic data to diagnose, monitor and inform cancer treatment. Its patented proprietary molecular diagnostics tests, the proprietary...

  • Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis

    Nov 2012

    By GlobalData

    Surgical Equipment

    40 Pages

    Rosetta Genomics, Ltd. (RGL) is a medical device company, based in Israel. The company develops and commercializes new diagnostic and therapeutic products based on group of genes known as microRNAs. It operates through its business segments such as, RG Laboratory Tests, RG Diagnostic Products, RG MicroRNA Technology and RG Therapeutic Products. RGL conducts several diagnostic test...

  • Oryzon Genomics S.A. Product Pipeline Review 2012

    Nov 2012

    By Global Markets Direct

    Pharmaceutical

    52 Pages

    Oryzon Genomics S.A. Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, Oryzon Genomics S.A. Product Pipeline Review 2012 provides data on the Oryzon Genomics S.A.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. ...

    USD 1500View Report
  • Discovery Genomics, Inc. Product Pipeline Review 2012

    Nov 2012

    By Global Markets Direct

    Pharmaceutical

    21 Pages

    Discovery Genomics, Inc. Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, Discovery Genomics, Inc. Product Pipeline Review 2012 provides data on the Discovery Genomics, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant...

    USD 1500View Report
  • AbGenomics International, Inc. Product Pipeline Review 2012

    Oct 2012

    By Global Markets Direct

    Pharmaceutical

    33 Pages

    AbGenomics International, Inc. Product Pipeline Review 2012 Global Market Directs pharmaceuticals report, AbGenomics International, Inc. Product Pipeline Review 2012 provides data on the AbGenomics International, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued...

    USD 1500View Report
  • Epigenomics AG (ECX) - Product Pipeline Analysis

    Aug 2012

    By GlobalData

    Market Guide

    35 Pages

    Epigenomics AG (Epigenomics) is a molecular diagnostics company. It develops, manufactures and sells cancer screening tests and diagnostics. The company classifies its product line into three categories namely, Cancer Screening Tests, Cancer Specialty Diagnostics and Research Products. Its lead test development program is in colorectal cancer. The companys molecular diagnostic products...

  • AutoGenomics, Inc. - Product Pipeline Analysis

    Jun 2012

    By GlobalData

    Surgical Equipment

    24 Pages

    AutoGenomics, Inc. (AutoGenomics) is a manufacturer of automated and integrated solution, based in the US. The company designs, develops, manufactures and markets molecular diagnostic products for the in-vitro diagnostic markets. Its products include INFINITI system which automates the discrete processes of genetic testing performed by clinical laboratories. INFINITI system consists of...

  • Oryzon Genomics - Product Pipeline Analysis

    Jun 2012

    By GlobalData

    Surgical Equipment

    29 Pages

    Oryzon Genomics (Oryzon) is a biotechnology company, based in Spain. It develops diagnostic and therapeutic products for the healthcare markets. The company markets its products through its brands name GynEC DX, Cxbladder and ColoBRAF. Oryzons product GynEC DX is a new diagnostic test for Endometrial cancer that forms in the lining of the uterus. Its Cxbladder product is a non-invasive...

  • Sirius Genomics Inc. - Product Pipeline Analysis

    Nov 2011

    By GlobalData

    SWOT Analysis

    18 Pages

    Sirius Genomics (Sirius) is a biotechnology company engaged in the development of diagnostic and pharmacogenetic products for the healthcare markets. The company develops genetic test reagents such as DNA based diagnostic (Dx) and pharmacogenetic (PGx) tests for the in vitro markets. Its products are linked up with complementary scientific, medical and business expertise for its effective...